Sign inJoin waitlistJoin the waitlist

Jamie Aye

Medical Director, Inpatient Pediatric Hematology/Oncology Services · University of Alabama Hospital

Credentials: · · · ·

History

Inpatient Pediatric Hematology/Oncology Services · University of Alabama Hospital
Present
University of Alabama Hospital
Present
University of Alabama Hospital
Present

Pediatric Hematology-Oncology
University of Alabama at Birmingham
2015–2016
University of South Carolina School of Medicine
2012–2015
Mercer University School of Medicine
2008–2012

Research

Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model
Journal of Medical Genetics · 2009 · 350 citations
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
PLoS ONE · 2021 · 28 citations
Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
Oncotarget · 2018 · 26 citations

Elizabeth Beierle
31 papers
Adele Williams
16 papers · 16 as a resident
Laura Bownes
14 papers · 14 as a resident
Laura Stafman
14 papers · 14 as a resident
Raoud Marayati
14 papers · 14 as a resident
Janet Julson
9 papers · 9 as a resident
Evan Garner
8 papers · 8 as a resident
Kimberly Whelan
7 papers
Sara Horton
6 papers · 6 as a fellow
Michael Erwin
5 papers · 2 as a resident
Rajkumar Venkatramani
5 papers
Christopher Willey
4 papers

Clinical trials

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2031
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027